Athlete's Foot Medication Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: A02F794106ACEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Athlete's Foot Medication in Global, including the following market information:

Global Athlete's Foot Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Athlete's Foot Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Clotrimazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Athlete's Foot Medication include Novartis, Perrigo, Mylan, Glenmark, Taro, Novitium, Strides Pharma and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Athlete's Foot Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Athlete's Foot Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Athlete's Foot Medication Market Segment Percentages, by Type, 2021 (%)

• Clotrimazole
• Econazole
• Ketoconazole
• Miconazole
• Terbinafine
• Sulconazole

Global Athlete's Foot Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Athlete's Foot Medication Market Segment Percentages, by Application, 2021 (%)

• Children
• Adult

Global Athlete's Foot Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Athlete's Foot Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Athlete's Foot Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Athlete's Foot Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Perrigo
• Mylan
• Glenmark
• Taro
• Novitium
• Strides Pharma
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Athlete's Foot Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Athlete's Foot Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ATHLETE'S FOOT MEDICATION OVERALL MARKET SIZE

2.1 Global Athlete's Foot Medication Market Size: 2021 VS 2028
2.2 Global Athlete's Foot Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Athlete's Foot Medication Players in Global Market
3.2 Top Global Athlete's Foot Medication Companies Ranked by Revenue
3.3 Global Athlete's Foot Medication Revenue by Companies
3.4 Top 3 and Top 5 Athlete's Foot Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies Athlete's Foot Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Athlete's Foot Medication Players in Global Market
  3.6.1 List of Global Tier 1 Athlete's Foot Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Athlete's Foot Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Athlete's Foot Medication Market Size Markets, 2021 & 2028
  4.1.2 Clotrimazole
  4.1.3 Econazole
  4.1.4 Ketoconazole
  4.1.5 Miconazole
  4.1.6 Terbinafine
  4.1.7 Sulconazole
4.2 By Type - Global Athlete's Foot Medication Revenue & Forecasts
  4.2.1 By Type - Global Athlete's Foot Medication Revenue, 2017-2022
  4.2.2 By Type - Global Athlete's Foot Medication Revenue, 2023-2028
  4.2.3 By Type - Global Athlete's Foot Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Athlete's Foot Medication Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Adult
5.2 By Application - Global Athlete's Foot Medication Revenue & Forecasts
  5.2.1 By Application - Global Athlete's Foot Medication Revenue, 2017-2022
  5.2.2 By Application - Global Athlete's Foot Medication Revenue, 2023-2028
  5.2.3 By Application - Global Athlete's Foot Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Athlete's Foot Medication Market Size, 2021 & 2028
6.2 By Region - Global Athlete's Foot Medication Revenue & Forecasts
  6.2.1 By Region - Global Athlete's Foot Medication Revenue, 2017-2022
  6.2.2 By Region - Global Athlete's Foot Medication Revenue, 2023-2028
  6.2.3 By Region - Global Athlete's Foot Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Athlete's Foot Medication Revenue, 2017-2028
  6.3.2 US Athlete's Foot Medication Market Size, 2017-2028
  6.3.3 Canada Athlete's Foot Medication Market Size, 2017-2028
  6.3.4 Mexico Athlete's Foot Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Athlete's Foot Medication Revenue, 2017-2028
  6.4.2 Germany Athlete's Foot Medication Market Size, 2017-2028
  6.4.3 France Athlete's Foot Medication Market Size, 2017-2028
  6.4.4 U.K. Athlete's Foot Medication Market Size, 2017-2028
  6.4.5 Italy Athlete's Foot Medication Market Size, 2017-2028
  6.4.6 Russia Athlete's Foot Medication Market Size, 2017-2028
  6.4.7 Nordic Countries Athlete's Foot Medication Market Size, 2017-2028
  6.4.8 Benelux Athlete's Foot Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Athlete's Foot Medication Revenue, 2017-2028
  6.5.2 China Athlete's Foot Medication Market Size, 2017-2028
  6.5.3 Japan Athlete's Foot Medication Market Size, 2017-2028
  6.5.4 South Korea Athlete's Foot Medication Market Size, 2017-2028
  6.5.5 Southeast Asia Athlete's Foot Medication Market Size, 2017-2028
  6.5.6 India Athlete's Foot Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Athlete's Foot Medication Revenue, 2017-2028
  6.6.2 Brazil Athlete's Foot Medication Market Size, 2017-2028
  6.6.3 Argentina Athlete's Foot Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Athlete's Foot Medication Revenue, 2017-2028
  6.7.2 Turkey Athlete's Foot Medication Market Size, 2017-2028
  6.7.3 Israel Athlete's Foot Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia Athlete's Foot Medication Market Size, 2017-2028
  6.7.5 UAE Athlete's Foot Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Athlete's Foot Medication Major Product Offerings
  7.1.4 Novartis Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Perrigo
  7.2.1 Perrigo Corporate Summary
  7.2.2 Perrigo Business Overview
  7.2.3 Perrigo Athlete's Foot Medication Major Product Offerings
  7.2.4 Perrigo Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.2.5 Perrigo Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Athlete's Foot Medication Major Product Offerings
  7.3.4 Mylan Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Glenmark
  7.4.1 Glenmark Corporate Summary
  7.4.2 Glenmark Business Overview
  7.4.3 Glenmark Athlete's Foot Medication Major Product Offerings
  7.4.4 Glenmark Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.4.5 Glenmark Key News
7.5 Taro
  7.5.1 Taro Corporate Summary
  7.5.2 Taro Business Overview
  7.5.3 Taro Athlete's Foot Medication Major Product Offerings
  7.5.4 Taro Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.5.5 Taro Key News
7.6 Novitium
  7.6.1 Novitium Corporate Summary
  7.6.2 Novitium Business Overview
  7.6.3 Novitium Athlete's Foot Medication Major Product Offerings
  7.6.4 Novitium Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.6.5 Novitium Key News
7.7 Strides Pharma
  7.7.1 Strides Pharma Corporate Summary
  7.7.2 Strides Pharma Business Overview
  7.7.3 Strides Pharma Athlete's Foot Medication Major Product Offerings
  7.7.4 Strides Pharma Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.7.5 Strides Pharma Key News
7.8 Teva
  7.8.1 Teva Corporate Summary
  7.8.2 Teva Business Overview
  7.8.3 Teva Athlete's Foot Medication Major Product Offerings
  7.8.4 Teva Athlete's Foot Medication Revenue in Global Market (2017-2022)
  7.8.5 Teva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Athlete's Foot Medication Market Opportunities & Trends in Global Market
Table 2. Athlete's Foot Medication Market Drivers in Global Market
Table 3. Athlete's Foot Medication Market Restraints in Global Market
Table 4. Key Players of Athlete's Foot Medication in Global Market
Table 5. Top Athlete's Foot Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Athlete's Foot Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Athlete's Foot Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies Athlete's Foot Medication Product Type
Table 9. List of Global Tier 1 Athlete's Foot Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Athlete's Foot Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Athlete's Foot Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Athlete's Foot Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Athlete's Foot Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Athlete's Foot Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Athlete's Foot Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Athlete's Foot Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Athlete's Foot Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Athlete's Foot Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Athlete's Foot Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Athlete's Foot Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Athlete's Foot Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Athlete's Foot Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Athlete's Foot Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Athlete's Foot Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Athlete's Foot Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Athlete's Foot Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Athlete's Foot Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Athlete's Foot Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Athlete's Foot Medication Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Athlete's Foot Medication Product Offerings
Table 32. Novartis Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 33. Perrigo Corporate Summary
Table 34. Perrigo Athlete's Foot Medication Product Offerings
Table 35. Perrigo Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Athlete's Foot Medication Product Offerings
Table 38. Mylan Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 39. Glenmark Corporate Summary
Table 40. Glenmark Athlete's Foot Medication Product Offerings
Table 41. Glenmark Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 42. Taro Corporate Summary
Table 43. Taro Athlete's Foot Medication Product Offerings
Table 44. Taro Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 45. Novitium Corporate Summary
Table 46. Novitium Athlete's Foot Medication Product Offerings
Table 47. Novitium Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 48. Strides Pharma Corporate Summary
Table 49. Strides Pharma Athlete's Foot Medication Product Offerings
Table 50. Strides Pharma Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)
Table 51. Teva Corporate Summary
Table 52. Teva Athlete's Foot Medication Product Offerings
Table 53. Teva Athlete's Foot Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Athlete's Foot Medication Segment by Type in 2021
Figure 2. Athlete's Foot Medication Segment by Application in 2021
Figure 3. Global Athlete's Foot Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Athlete's Foot Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Athlete's Foot Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Athlete's Foot Medication Revenue in 2021
Figure 8. By Type - Global Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 12. US Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 16. Germany Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 24. China Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 30. Brazil Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Athlete's Foot Medication Revenue Market Share, 2017-2028
Figure 33. Turkey Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Athlete's Foot Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Perrigo Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Glenmark Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Taro Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novitium Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Strides Pharma Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Athlete's Foot Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)